2022
DOI: 10.1007/s11274-021-03212-1
|View full text |Cite
|
Sign up to set email alerts
|

Advances and prospects in metabolic engineering of Escherichia coli for L-tryptophan production

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
11
0
1

Year Published

2022
2022
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 20 publications
(13 citation statements)
references
References 163 publications
1
11
0
1
Order By: Relevance
“…Genetically engineered E. coli strains have been developed to produce phytase, enhancing nutrient availability and digestion in animals [48]. Furthermore, genetically engineered E. coli can be used for the production of various amino acids or vitamins that are essential for animal health and growth [49]. Through genetic modifications, E. coli can be engineered to produce specific nutrients that may be lacking in the animal's diet or required in higher quantities.…”
Section: Probiotics and Postbioticsmentioning
confidence: 99%
“…Genetically engineered E. coli strains have been developed to produce phytase, enhancing nutrient availability and digestion in animals [48]. Furthermore, genetically engineered E. coli can be used for the production of various amino acids or vitamins that are essential for animal health and growth [49]. Through genetic modifications, E. coli can be engineered to produce specific nutrients that may be lacking in the animal's diet or required in higher quantities.…”
Section: Probiotics and Postbioticsmentioning
confidence: 99%
“…L-Tryptophan is an essential amino acid for the human body and its deficiency can cause phenylketonuria, cataracts, depression, and myocardial fibrosis. 31,32,48 Furthermore, the photoluminescence decay of Ti 3 C 2 nanosheets after mixing with L-tryptophan was also tested, as shown in the red curve of Fig. 2f.…”
Section: The Detection Of L-tryptophan Based On Up-conversion Fluores...mentioning
confidence: 99%
“…Moleküler biyoloji ve biyofarmasötik uygulamalardaki yaygın kullanımı, maliyet etkinliği ve ölçeklenebilirliği ile birleştiğinden dolayı, E. coli ayrıca terapötik pDNA üretimi için ana konak olarak seçilmiştir [24]. Örneğin; ilaç, gıda ve yem endüstrisi için önemli bir hammadde olan Ltriptofanın Escherichia coli tarafından yüksek verimli üretimi büyük ilgi görmüştür [25]. Temel bir aromatik amino asit olarak L-fenilalanin (L-Phe), farmasötikler, yapay tatlandırıcılar vb.…”
Section: Prokaryotik Biyosentez Platformu: Escherichia Coliunclassified